Correlation Between Medicus Pharma and Lipocine

Can any of the company-specific risk be diversified away by investing in both Medicus Pharma and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicus Pharma and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medicus Pharma Ltd and Lipocine, you can compare the effects of market volatilities on Medicus Pharma and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicus Pharma with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicus Pharma and Lipocine.

Diversification Opportunities for Medicus Pharma and Lipocine

-0.2

Correlation Coefficient

Medicus Pharma  Lipocine

Good diversification

The 3 months correlation between Medicus and Lipocine is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Medicus Pharma Ltd and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Medicus Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicus Pharma Ltd are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Medicus Pharma i.e., Medicus Pharma and Lipocine go up and down completely randomly.

Pair Corralation between Medicus Pharma and Lipocine

Given the investment horizon of 90 days Medicus Pharma Ltd is expected to generate 1.79 times more return on investment than Lipocine. However, Medicus Pharma is 1.79 times more volatile than Lipocine. It trades about 0.05 of its potential returns per unit of risk. Lipocine is currently generating about -0.02 per unit of risk. If you would invest  280.00  in Medicus Pharma Ltd on October 9, 2024 and sell it today you would earn a total of  8.00  from holding Medicus Pharma Ltd or generate 2.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Medicus Pharma Ltd  vs.  Lipocine

Medicus Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medicus Pharma Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Lipocine

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lipocine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Lipocine is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Medicus Pharma and Lipocine

The main advantage of trading using opposite Medicus Pharma and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicus Pharma position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.

The idea behind Medicus Pharma Ltd and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.